Biggest News Aggregation in the World
📰 Resented News

Page 20 - Resented News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Resented. Real-time updates on events, politics, business and more.

IMFINZI-based treatment before and after surgery reduced the risk of disease recurrence, progression events or death by 32% in resectable non-small cell lung cancer in the AEGEAN Phase III trial

Results presented at AACR 2023 found that four times as many patients treated with Imfinzi plus chemotherapy before surgery achieved pathologic complete response versus those treated with neoadjuvant... | April 16, 2023
United Kingdom United States Johnv Heymach Le Chevalier Daiichi Sankyo Susan Galbraith

Merck's KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival Compared to Chemotherapy Alone in Patients With Advanced or Unresectable Biliary Tract Cancer

Results from Phase 3 KEYNOTE-966 to be presented at AACR 2023 Annual Meeting during Clinical Trials Plenary Session, included in official meeting press program and published simultaneously in The... | April 16, 2023
United States San Francisco Robin Kate Kelley Merck Co Inc Statement Of Merck Co Inc Exchange Commission

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

23andMe Announces Phase 1 Results from the First-in-Human Phase 1/2a Study of 23ME-00610, an Investigational Antibody Targeting CD200R1

First clinical results to be presented at the AACR Annual Meeting 2023 showed 23ME-00610 demonstrated an acceptable safety and tolerability profile, with favorable pharmacokinetics and peripheral... | April 14, 2023
United States Head Of Therapeutics Development American Association For Cancer Research Eastern Cooperative Oncology Group Me Holding Co American Association

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science